Serological and Clinical one year follow-up of Patients with Erythema migrans treated in a Romanian Infectious Disease Hospital

1. Jaenson TGT, Jaenson DGE, Eisen L, Petersson E, Lindgren E. Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden. Parasit Vectors. 2012;10:5-8. DOI: 10.1186/1756-3305-5-8.10.1186/1756-3305-5-8Search in Google Scholar

2. Berglund J, Eitrem R, Ornstein K. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995;333:1319-27. DOI: 10.1056/ NEJM19951116333200410.1056/NEJM199511163332004Search in Google Scholar

3. Strle F. Lyme borreliosis in Slovenia. Zentralbl Bakteriol. 1999;289(5-7):643-52. DOI: 10.1016/S0934-8840(99)80023-110.1016/S0934-8840(99)80023-1Search in Google Scholar

4. Zöldi V, Juhász A, Nagy C, Papp Z, Egyed L. Tickborne encephalitis and Lyme disease in Hungary: the epidemiological situation between 1998 and 2008. Vector Borne Zoonotic Dis. 2013 Apr;13(4):256-65. DOI: 10.1089/vbz.2011.090510.1089/vbz.2011.090523428090Search in Google Scholar

5. Mukhacheva TA, Kovalev SY. Multilocus sequence analysis of Borrelia burgdorferi s.l. in Russia. Ticks Tick Borne Dis. 2013 Jun;4(4):275-9. DOI: 10.1016/j. ttbdis.2013.02.004Search in Google Scholar

6. Coipan EC, Vladimirescu AF. Ixodes ricinus ticks (Acari: Ixodidae): vectors for Lyme disease spirochetes in Romania. Exp Appl Acarol. 2011;54(3):293-300. DOI: 10.1007/s10493-011-9438-410.1007/s10493-011-9438-421431930Search in Google Scholar

7. Kiss T, Cadar D, Krupaci AF, Bordeanu A, Brudaşcă GF, Mihalca AD, et al. Serological reactivity to Borrelia burgdorferi sensu lato in dogs and horses from distinct areas in Romania. Vector Borne Zoonotic Dis. 2011;11(9):1259-62. DOI: 10.1089/vbz.2010.025410.1089/vbz.2010.025421612524Search in Google Scholar

8. Hristea A, Hristescu S, Ciufecu C, Vasile A. Seroprevalence of Borrelia burgdorferi in Romania. Eur J Epidemiol. 2001;17(9):891-6. DOI: 10.1023/A:101560072990010.1023/A:1015600729900Search in Google Scholar

9. Stanek G, O’Connell S, Cimmino M, Aberer E, Kristoferitsch W, Granstrom M, et al. European Union Concerted Action on Risk Assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr; 1996;108(23):741-7.Search in Google Scholar

10. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2006;43(9):1089-134. DOI: 10.1086/50866710.1086/50866717029130Search in Google Scholar

11. Schulte-Spechtel U, Hillermann R, Liegl G, Wilske B, Fingerle V. Improvement of Lyme Borreliosis Serodiagnosis by a Newly Developed Recombinant Immunoglobulin G (IgG) and IgM Line Immunoblot Assay and Addition of VlsE and DbpA Homologues Gereon Goettner. J Clin Microbiol. 2005;43(8):3602-9. DOI: 10.1128/JCM.43.8.3602-3609.200510.1128/JCM.43.8.3602-3609.2005123398416081885Search in Google Scholar

12. Rosner B. Fundamentals of Biostatistics, 7th Edition. Duxbury Press, 2010.Search in Google Scholar

13. Piesman J, Gern L. Lyme borreliosis in Europe and North America. Parasitology. 2004;129 Suppl: S191-220. DOI: 10.1017/S003118200300469410.1017/S0031182003004694Search in Google Scholar

14. Tijsse-Klasen E, Pandak N, Hengeveld P, Takumi K, Koopmans MPG, Sprong H. Ability to cause erythema migrans differs between Borrelia burgdorferi sensu lato isolates. Parasit Vectors. 2013;6:23. DOI: 10.1186/1756-3305-6-2310.1186/1756-3305-6-23359912623339549Search in Google Scholar

15. Svihrova V, Hudeckova H, Jesenak M, Schwarzova K, Kostanova Z, Ciznar I. Lyme borreliosis--analysis of the trends in Slovakia1999-2008. Folia Microbiol. 2011;56(3):270-5. DOI: 10.1007/s12223-011-0036-y10.1007/s12223-011-0036-y21607749Search in Google Scholar

16. Bartosik K, Lachowska-Kotowska P, Szymańska J, Pabis A, Buczek A. Lyme borreliosis in south-eastern Poland: relationships with environmental factors and medical attention standards. Ann Agric Environ Med. 2011;18(1):131-7.Search in Google Scholar

17. Van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis. 1993 Oct;17(4):708-17. DOI: 10.1093/clinids/17.4.70810.1093/clinids/17.4.7087903558Search in Google Scholar

18. Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, et al. Comparison of culture- confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med. 1999;130(1):32-6. DOI: 10.7326/0003-4819-130-1-199901050-0000610.7326/0003-4819-130-1-199901050-000069890847Search in Google Scholar

19. Richter D, Klug B, Spielman A, Matuschka FR. Adaptation of Diverse Lyme Disease Spirochetes in a Natural Rodent Reservoir Host. Infect Immun 2004;72(4):2442-4. DOI: 10.1128/IAI.72.4.2442-2444.200410.1128/IAI.72.4.2442-2444.200437519115039378Search in Google Scholar

20. Strle F, Ružić-Sabljić E, Logar M, Maraspin V, Lotrič-Furlan S, Cimperman J, et al. Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii. Vector Borne Zoonotic Dis. 2011;11(9):1253-8 DOI: 10.1089/vbz.2010.023010.1089/vbz.2010.023021612533Search in Google Scholar

21. Dandache P, Nadelman RB. Erythema migrans. Infect Dis Clin North Am. 2008;22(2):235-60. DOI: 10.1016/j.idc.2007.12.01210.1016/j.idc.2007.12.01218452799Search in Google Scholar

22. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379(9814):461-73. DOI: 10.1016/ S0140-6736(11)60103-7Search in Google Scholar

23. Stupica D, Lusa L, Cerar T, Ružić-Sabljić E, Strle F. Comparison of post-Lyme Borreliosis symptoms in erythema migrans patients with positive and negative Borrelia burgdorferi sensu lato skin culture. Vector Borne Zoonotic Dis. 2011;11(7):883-9. DOI: 10.1089/ vbz.2010.001810.1089/vbz.2010.001821083376Search in Google Scholar

24. Glatz M, Golestani M, Kerl H, Müllegger RR. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients. Arch Dermatol. 2006;142(7):862-8. DOI: 10.1001/archderm.142.7.86210.1001/archderm.142.7.86216847202Search in Google Scholar

25. Dattwyler RJ, Luft BJ, Kunkel MJ, Finkel MF, Wormser GP, Rush TJ, et al. Ceftriaxone compared with doxycicline for the treatment of acute disseminated Lyme disease. N Engl J Med. 1997;337(5):289-94. DOI: 10.1056/NEJM19970731337050110.1056/NEJM1997073133705019233865Search in Google Scholar

26. Massarotti EM, Luger SW, Rahn DW, Messner RP, Wong JB, Johnson RC, et al. Treatment of early Lyme disease. Am J Med. 1992;92(4):396-403. DOI: 10.1016/0002-9343(92)90270-L10.1016/0002-9343(92)90270-LSearch in Google Scholar

27. Weber K, Wilske B, Preac-Mursic V, Thurmayr R. Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. Infection. 1993; 21(6):367-372. DOI: 10.1007/BF0172891510.1007/BF01728915Search in Google Scholar

28. Nowakowski J, Nadelman RB, Sell R, McKenna D, Cavaliere LF, Holmgren D. et al. Longterm follow-up of patients with culture-confirmed Lyme disease. Am J Med. 2003;115(2):91-6. DOI: 10.1016/S0002-9343(03)00308-510.1016/S0002-9343(03)00308-5Search in Google Scholar

29. Wormser, GP, Ramanathan, R, Nowakowski, J, McKenna, D, Holmgren D, Visintainer P, et al. Duration of antibiotic therapy for early Lyme disease. Ann Intern Med.2003;138(9):697-704. DOI: 10.7326/0003-4819-138-9-200305060-0000510.7326/0003-4819-138-9-200305060-0000512729423Search in Google Scholar

30. Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis. 2001;33(6):780-5. DOI: 10.1086/32266910.1086/32266911512082Search in Google Scholar

31. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B-cells. Science. 2002;298(5601):2199-202. DOI: 10.1126/science.107607110.1126/science.107607112481138Search in Google Scholar

32. Aguero Rosenfeld ME, Nowakowski J, Bittker S, CooperD, Nadelman RB, Wormser GP. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol. 1996;34(1):1-9.10.1128/jcm.34.1.1-9.19962287188748261Search in Google Scholar

33. Mullegger RR, Glatz M. Is serological follow-up useful for patients with cutaneous Lyme borreliosis? Curr Probl Dermatol. 2009;37:178-82. DOI: 10.1159/000213075 10.1159/00021307519367102Search in Google Scholar